2-166037819-C-T
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_001165963.4(SCN1A):c.2903G>A(p.Cys968Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C968F) has been classified as Pathogenic.
Frequency
Consequence
NM_001165963.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN1A | ENST00000674923.1 | c.2903G>A | p.Cys968Tyr | missense_variant | Exon 18 of 29 | NM_001165963.4 | ENSP00000501589.1 | |||
SCN1A | ENST00000303395.9 | c.2903G>A | p.Cys968Tyr | missense_variant | Exon 17 of 28 | 5 | ENSP00000303540.4 | |||
SCN1A | ENST00000375405.7 | c.2870G>A | p.Cys957Tyr | missense_variant | Exon 15 of 26 | 5 | ENSP00000364554.3 | |||
SCN1A | ENST00000409050.1 | c.2819G>A | p.Cys940Tyr | missense_variant | Exon 15 of 26 | 5 | ENSP00000386312.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Cys968 amino acid residue in SCN1A. Other variant(s) that disrupt this residue have been observed in individuals with SCN1A-related conditions (PMID: 27652284), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SCN1A protein function. This variant has been observed in individual(s) with early onset epilepsy (Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 861214). This variant is not present in population databases (ExAC no frequency). This sequence change replaces cysteine with tyrosine at codon 968 of the SCN1A protein (p.Cys968Tyr). The cysteine residue is highly conserved and there is a large physicochemical difference between cysteine and tyrosine. -
Developmental and epileptic encephalopathy 6B Pathogenic:1
The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Missense variant In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.96 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 1.00 (>=0.6, sensitivity 0.72 and precision 0.9)]. Same nucleotide change resulting in same amino acid change has been previously reported to be associated with SCN1A related disorder (ClinVar ID: VCV000861214).The variant has been previously reported as assumed (i.e. paternity and maternity not confirmed) de novo in at least one similarly affected unrelated individual (PMID: 27652284). Different missense changes at the same codon (p.Cys968Arg, p.Cys968Gly, p.Cys968Phe, p.Cys968Trp) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000189992, VCV001068194 /PMID: 26096185, 27652284, 32090326). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at